US Patent Issued to ELLEX MEDICAL on Jan. 20 for "Photobiomodulation device for treating retinal disease" (Australian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,970, issued on Jan. 20, was assigned to ELLEX MEDICAL PTY LTD. (Mawson Lakes, Australia).

"Photobiomodulation device for treating retinal disease" was invented by Wei Xia (Mawson Lakes, Australia), Victor Previn (Mawson Lakes, Australia) and Robert Casson (North Adelaide, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "An ophthalmic treatment device for photobiomodulation of a retina comprising: a treatment light source producing a continuous wave or quasi-continuous wave output beam having a wavelength in the range of 600 nm to 1000 nm and a power in the range of 1 mW to 500 mW; a beam homogenizing module that homogenizes the output beam o...